Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 10836281)


Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.

Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU.

Mol Psychiatry. 2013 Jan;18(1):53-66. doi: 10.1038/mp.2011.143. Epub 2011 Nov 29. Review.


Safety and tolerability of antipsychotics: focus on amisulpride.

Juruena MF, de Sena EP, de Oliveira IR.

Drug Healthc Patient Saf. 2010;2:205-11. doi: 10.2147/DHPS.S6226. Epub 2010 Oct 1.


How to obtain NNT from Cohen's d: comparison of two methods.

Furukawa TA, Leucht S.

PLoS One. 2011 Apr 27;6(4):e19070. doi: 10.1371/journal.pone.0019070.


Update on the management of symptoms in schizophrenia: focus on amisulpride.

Mortimer AM.

Neuropsychiatr Dis Treat. 2009;5:267-77. Epub 2009 May 20.


The use of amisulpride in the treatment of acute psychosis.

Nuss P, Hummer M, Tessier C.

Ther Clin Risk Manag. 2007 Mar;3(1):3-11.


Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features.

Rabinowitz J, Levine SZ, Barkai O, Davidov O.

Schizophr Bull. 2009 Jul;35(4):775-88. doi: 10.1093/schbul/sbn005. Epub 2008 Feb 26.


Quality of life in schizophrenic patients.

Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bousoño M.

Dialogues Clin Neurosci. 2007;9(2):215-26. Review.


Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

Leucht S, Engel RR, Bäuml J, Davis JM.

Schizophr Bull. 2007 Jan;33(1):183-91. Epub 2006 Aug 11.


The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.

Herrera-Estrella M, Apiquian R, Fresan A, Sanchez-Torres I.

BMC Psychiatry. 2005 May 3;5:22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk